4.10:

Asthma-IV: Diagnostic and Management

JoVE Core
Medical-Surgical Nursing
Zum Anzeigen dieser Inhalte ist ein JoVE-Abonnement erforderlich.  Melden Sie sich an oder starten Sie Ihre kostenlose Testversion.
JoVE Core Medical-Surgical Nursing
Asthma-IV: Diagnostic and Management

14 Views

01:30 min

October 25, 2024

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:

Clinical Assessment for Asthma:

This is the first step in diagnosing and managing asthma. It includes:

  1. Detailed Medical History: This includes asking about symptoms such as wheezing, coughing, chest tightness, and breathlessness. Information about triggers like exercise, allergens, or cold air is crucial.
  2. Physical Examination: Focuses on the respiratory system. The clinician listens to the lungs for wheezing, checks for allergic rhinitis or eczema (often associated with asthma), and evaluates breathing patterns.
  3. Symptom Pattern Evaluation: Understanding symptom frequency, duration, and intensity helps categorize asthma severity.
  4. Family History: Assessing if there's a family history of asthma or other allergic conditions.

Lung Function Tests:

These tests assess the amount and speed of air that can be inhaled and exhaled, providing a quantitative measure of lung function.

  1. Spirometry: The primary diagnostic test for asthma involves checking the Forced Expiratory Volume in one second (FEV1) and the Forced Vital Capacity (FVC). The FEV1/FVC ratio is calculated, and a value below the normal range often less than 70% indicates airflow obstruction, a key characteristic of asthma.
  2. Peak Flow Meter: Assessing the peak expiratory flow rate (PEFR) provides insight into the speed at which air is expelled from the lungs.
  3. Bronchoprovocation Testing: This includes methacholine challenge and exercise challenge tests, used when spirometry results are typical but asthma is still suspected. These tests assess airway hyperresponsiveness.
  4. Fraction of Exhaled Nitric Oxide (FeNO): Measures eosinophilic inflammation in the lungs, aiding in identifying allergic asthma.

Pharmacological Interventions:

Asthma treatment involves two primary types of medications:

  1. Long-Term Control Medications are used daily to maintain control of persistent asthma.
    1. Inhaled Corticosteroids reduce inflammation and sensitivity of the airways.
    2. Long-acting beta-agonists (LABAs) relax airway muscles to improve breathing.
    3. Leukotriene Modifiers inhibit leukotrienes, which are compounds that play a role in causing asthma symptoms.
  1. Quick-Relief Medications: Provide rapid relief from acute asthma symptoms.
    1. Short-acting beta-agonists (SABAs): Rapid bronchodilators, relieving acute symptoms.
    2. Anticholinergics: Relax and open airways quickly.
    3. Oral and Intravenous Corticosteroids: For severe asthma exacerbations.

Inhalation Devices:

Effective delivery of asthma medications is crucial and achieved through various devices:

  1. Metered-Dose Inhalers (MDIs): Spray medication. Requires coordination between actuation and inhalation.
  2. Dry Powder Inhalers (DPIs): Releases medication as a dry powder. Inhalation must be quick and deep.
  3. Nebulizers: Converts liquid medication into a mist, suitable for patients with difficulty using inhalers, like young children or those with severe asthma.
  4. Soft Mist Inhalers (SMIs): Produces a fine mist without solid inhalation.

Each device requires its own technique for optimal medication delivery. The device selection is contingent upon the patient's age, coordination, preference, and the type of medication prescribed. Regular review of inhalation techniques is essential to ensure effective asthma management.